© 2018 by Magellan Bioanalytics 

CHARTING THE PATH TO

PRECISION HEALTHCARE

Magellan Bioanalytics generates human health data from analysis of the "hidden proteome”, a fraction of human serum that contains >30,000 potential biomarkers.  Our proprietary technology has successfully identified biomarkers that predict or stage disease in various indications, from breast cancer to Alzheimer's.

Our current partnerships discussions are centered around identifying biomarkers that guide Alzheimer's drug development, and markers that predict patient response to cancer immunotherapy.

We are actively looking at additional partners to leverage our technology in other areas of human health.

Salt Lake City 

5201 Green St, Suite 160

Salt Lake City, UT 84123

Tel: 801-664-7241

mhansen@mag-bio.com

San Diego

3142 Vista Way, Suite 308

Oceanside, CA 92056

Tel: 760-713-6613

moddou@mag-bio.com